P39900 (MMP12_HUMAN) Homo sapiens (Human)

Macrophage metalloelastase UniProtKBInterProSTRINGInteractive Modelling

470 aa; Sequence (Fasta)

Available Structures

86 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Productive complex between MMP-12 and synthetic triple-helical collagen, revealed through paramagne…
2n8r
 Heteromer
100-263
2×ZN; 3×CA;
Assess
Potempin A (PotA) from Tannerella forsythia in complex with the catalytic domain of human MMP-12
8b2n
 Heteromer
G8UM88; 		106-263
3×CA; 2×ZN;
Assess
Crystal Structure of MMP-12 complexed to 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl-4-(4-ethox…
1utt
homo-6-mer106-264
6×HAE; 6×CP8; 12×ZN; 24×CA;
Assess
Crystal Structure of MMP-12 complexed to (2R)-3-({[4-[(pyridin-4-yl)phenyl]-thien-2-yl}carboxamido)…
1utz
homo-6-mer106-264
9×PF3; 6×HAE; 12×ZN; 12×CA;
Assess
Crystal structure of the catalytic domain of MMP-12 in complex with a twin inhibitor.
4h30
homo-2-mer106-263
4×ZN; 6×CA; 8×GOL; 1×0ZD; 1×PEG;
Assess
Crystal structure of the catalytic domain of MMP-12 in complex with a twin inhibitor.
4h49
homo-2-mer106-263
4×ZN; 6×CA; 2×PGO; 1×DMS; 2×PEG; 1×L29; 1×GOL;
Assess
Crystal structure of full-length human MMP-12
3ba0
monomer106-470
2×ZN; 4×CA; 1×HAE;
Assess
Solution structure of the hemopexin-like domain of MMP12
2jxy
monomer278-470
1×CA;
Assess
Crystal Structure Analysis of human Macrophage Elastase MMP-12
1jiz
monomer100-264
2×ZN; 3×CA; 1×CGS;
Assess
Solution structure of the wild-type catalytic domain of human matrix metalloproteinase 12 (MMP-12) …
2k2g
monomer100-263
2×ZN; 1×DSV;
Assess
Membrane Bilayer complex with Matrix Metalloproteinase-12 at its Alpha-face
2mlr
monomer100-263
2×ZN; 3×CA; 125×PX4;
Assess
NMR Solution Structure of the Inhibitor-Free State of Macrophage Metalloelastase (MMP-12)
2poj
monomer100-263
2×ZN; 3×CA;
Assess
Membrane Bilayer complex with Matrix Metalloproteinase-12 at its Beta-face
2mls
monomer100-263
2×ZN; 3×CA; 125×PX4;
Assess
Binary enzyme-product complexes of human MMP12
1os9
monomer106-268
2×ZN; 3×CA;
Assess
MMP12 complex with a beta hydroxy carboxylic acid
2wo8
monomer106-268
2×ZN; 1×CA; 1×077; 2×SO4;
Assess
Ternary enzyme-product-inhibitor complexes of human MMP12
1os2
monomer106-268
2×ZN; 3×CA; 1×HAE;
Assess
MMP12 complex with a beta hydroxy carboxylic acid
2wo9
monomer106-267
2×ZN; 1×CA; 1×068; 3×SO4;
Assess
MMP12 complex with a beta hydroxy carboxylic acid
2woa
monomer106-267
4×SO4; 2×ZN; 1×CA; 1×576;
Assess
Crystal structure of MMP-12 complexed to 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl-4-(4-ethox…
1ros
monomer106-264
2×ZN; 3×CA; 1×DEO;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with acetohydroxamic acid at ato…
1y93
monomer106-263
2×ZN; 3×CA; 1×HAE;
Assess
Crystal structure of human MMP-12 (Macrophage Elastase) at true atomic resolution
1jk3
monomer106-263
2×ZN; 3×CA; 1×BAT;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-(2-nitroso-…
3f17
monomer106-263
2×ZN; 3×CA; 1×HS4;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2…
3f19
monomer106-263
2×ZN; 3×CA; 1×HS6;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2…
3f18
monomer106-263
2×ZN; 3×CA; 1×HS5;
Assess
Human MMP-12 complexed with the peptide IAG
2oxw
monomer106-263
2×ZN; 3×CA;
Assess
Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhib…
4gql
monomer106-263
2×ZN; 3×CA; 1×R47;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor (R)-N-(3-hydr…
3f16
monomer106-263
2×ZN; 3×CA; 1×HS3;
Assess
Crystal structure of MMP12 in complex with inhibitor BE7.
6ekn
monomer106-263
2×ZN; 3×CA; 1×B9N; 1×EDO;
Assess
Crystal structure of a mutated catalytic domain of Human MMP12 in complex with an hydroxamate analo…
5d2b
monomer106-263
2×ZN; 3×CA; 1×56O;
Assess
Uninhibited form of human MMP-12
2oxu
monomer106-263
2×ZN; 3×CA;
Assess
Crystal structure of a dimeric based inhibitor JG34 in complex with the MMP-12 catalytic domain
7ovy
monomer106-263
2×ZN; 3×CA; 1×2IF; 1×EDO; 1×PGR;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-(2-nitroso-…
3f1a
monomer106-263
2×ZN; 3×CA; 1×HS7;
Assess
MMP12 in a complex with the dimeric adduct: 5-(5-phenylhydantoin)-5-phenylhydantoin
3uvc
monomer106-263
3×ZN; 4×CA; 3×IMD; 3×CL; 1×0D2; 1×EDO;
Assess
Crystal structure of the catalytic domain of Human MMP12 in complex with a carboxylate inhibitor re…
5cxa
monomer106-263
2×ZN; 3×CA; 1×55L;
Assess
Crystal structure of MMP12 in complex with carboxylic inhibitor LP165.
6eox
monomer106-263
2×ZN; 3×CA; 1×BKW;
Assess
Crystal structure of a mutated catalytic domain of Human MMP12 in complex with RXP470
5czm
monomer106-263
2×ZN; 3×CA; 1×R47;
Assess
Human MMP12 in complex with non-zinc chelating inhibitor
3ljg
monomer106-263
2×ZN; 3×CA; 1×HAE; 1×EEF; 2×P6G;
Assess
Crystal structure of a double mutant catalytic domain of Human MMP12 in complex with an hydroxamate…
5d3c
monomer106-263
2×ZN; 3×CA; 1×56O;
Assess
Crystal structure of human MMP-12 in complex with acetohydroxamic acid and a bicyclic inhibitor
2hu6
monomer106-263
2×ZN; 3×CA; 1×37A; 1×HAE;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor NNGH at 1.3 A…
1rmz
monomer106-263
2×ZN; 3×CA; 1×NGH;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor NNGH
5lab
monomer106-263
2×ZN; 3×CA; 1×NGH;
Assess
Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhib…
4gr3
monomer106-263
2×ZN; 3×CA; 1×R45;
Assess
Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhib…
4gr0
monomer106-263
2×ZN; 3×CA; 1×R4B;
Assess
Crystal structure of the catalytic domain of Human MMP12 in complex with a broad spectrum hydroxama…
4h76
monomer106-263
2×ZN; 3×CA; 1×10B; 3×PGO; 3×PEG; 1×GOL;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-hydroxy-2-(…
3n2v
monomer106-263
2×ZN; 3×CA; 1×JT5;
Assess
Human MMP12 in complex with L-glutamate motif inhibitor
3ts4
monomer106-263
2×ZN; 3×CA; 1×EEG; 1×IMD; 1×GOL;
Assess
Crystal structure of the catalytic domain of Human MMP12 in complex with a selective carboxylate ba…
4h84
monomer106-263
2×ZN; 3×CA; 1×Y38; 4×PGO; 1×PGR; 4×GOL; 3×PEG;
Assess
Human MMP12 in complex with L-glutamate motif inhibitor
4efs
monomer106-263
2×ZN; 3×CA; 1×E37; 1×GOL; 2×EDO; 1×PGR; 3×PGO; 1×IMD;
Assess
Human MMP12 in complex with a PEG-linked bifunctional L-glutamate motif inhibitor
4i03
monomer106-263
2×ZN; 3×CA; 1×L88; 3×GOL; 2×PGO; 2×DMS; 4×EDO; 1×PEG;
Assess
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor (S)-N-(2,3-di…
3f15
monomer106-263
2×ZN; 3×CA; 1×HS1;
Assess
Human MMP12 in complex with 3-(5-(1,2-dithiolan-3-yl)pentanamido)propane-1-sulfonate
5n5j
monomer106-263
2×ZN; 3×CA; 1×HAE; 1×8NT;
Assess
Human MMP12 in complex with non-zinc chelating inhibitor
3lil
monomer106-263
2×ZN; 3×CA; 1×EEA; 1×HAE;
Assess
Crystal structure of MMP12 mutant K421A in complex with RXP470.1 conjugated with fluorophore Cy5,5 …
5l7f
monomer106-263
2×ZN; 3×CA; 1×BR; 2×EDO; 1×R47; 1×6PJ;
Assess
Catalytic domain of human MMP-12 complexed with hydroxamic acid and paramethoxy-sulfonyl amide
3lka
monomer106-263
2×ZN; 3×CA; 1×HAE; 1×M4S;
Assess
Human MMP12 in complex with non-zinc chelating inhibitor
3lik
monomer106-263
2×ZN; 3×CA; 1×EEG; 1×HAE; 3×P6G;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-Hydroxy-2-(…
3nx7
monomer106-263
2×ZN; 3×CA; 1×NHK;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor paramethoxy-s…
3lk8
monomer106-263
2×ZN; 3×CA; 1×Z79;
Assess
Human MMP-12 catalytic domain in complex with*N*-Hydroxy-2-(2-phenylethylsulfonamido)acetamide
3rts
monomer106-263
2×ZN; 3×CA; 1×KLG;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-hydroxy-2-(…
3n2u
monomer106-263
2×ZN; 3×CA; 1×D3X;
Assess
Human MMP-12 catalytic domain in complex with*(R)-N*-Hydroxy-1-(phenethylsulfonyl)pyrrolidine-2-car…
3rtt
monomer106-263
2×ZN; 3×CA; 1×KLH;
Assess
Human MMP12 in complex with non-zinc chelating inhibitor
3lir
monomer106-263
2×ZN; 3×CA; 1×EEC; 1×GLY;
Assess
Human MMP12 catalytic domain in complex with AP280
6rd0
monomer106-263
2×ZN; 3×CA; 1×K0Q; 1×HAE;
Assess
Human MMP-12 in complex with two peptides PQG and IAG
2oxz
monomer106-263
2×ZN; 3×CA;
Assess
Unraveling hidden allosteric regulatory sites in structurally homologues metalloproteases
4ijo
monomer106-263
2×ZN; 3×CA;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor (R)-2-(4-meth…
3ehy
monomer106-263
2×ZN; 3×CA; 1×TBL;
Assess
Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor (R)-2-(biphen…
3ehx
monomer106-263
2×ZN; 3×CA; 1×BDL;
Assess
Discovery of the first orally bioavailable ADAMTS7 inhibitor BAY-9835
8rij
monomer106-263
2×ZN; 3×CA; 1×A1H07; 1×PEG; 1×CL;
Assess
Does a Fast Nuclear Magnetic Resonance Spectroscopy- and X-Ray Crystallography Hybrid Approach Prov…
2w0d
monomer106-263
3×ZN; 3×CA; 3×ACT; 1×CGS;
Assess
Human MMP12 in complex with L-glutamate motif inhibitor
3tsk
monomer106-263
2×ZN; 3×CA; 1×QEG;
Assess
Human MMP12 catalytic domain in complex with*N*-Hydroxy-2-(2-(4-methoxyphenyl)ethylsulfonamido)acet…
4guy
monomer106-263
2×ZN; 3×CA; 1×KLJ;
Assess
Crystal structure of MMP12 in complex with RXP470.1 conjugated with fluorophore Cy5,5 in space grou…
5l79
monomer106-263
2×ZN; 3×CA; 1×R47; 1×6PJ; 4×EDO; 1×GOL;
Assess
Human MMP12 (catalytic domain) in complex with AP316
6rly
monomer106-263
2×ZN; 3×CA; 1×HAE; 1×K8T;
Assess
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated ar…
5i0l
monomer106-263
1×H27; 2×ZN; 3×CA; 1×PGO; 1×EDO; 1×PEG;
Assess
Solution Structure of MMP12 in the presence of N-isobutyl-N-4-methoxyphenylsulfonyl]glycyl hydroxam…
1z3j
monomer106-263
2×ZN; 3×CA; 1×NGH;
Assess
Solution structure of human macrophage elastase (MMP-12) catalytic domain complexed with a gamma-ke…
2z2d
monomer106-263
2×ZN; 3×CA; 1×HSI;
Assess
Solution Structure of matrix metalloproteinase 12 (MMP12) in the presence of N-Isobutyl-N-[4-methox…
1ycm
monomer106-263
2×ZN; 3×CA; 1×NGH;
Assess
Crystal structure of MMP12 in complex with inhibitor BE4.
6ela
monomer107-263
2×ZN; 3×CA; 1×B9Z; 1×DIO;
Assess
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated tr…
5i43
monomer107-263
2×ZN; 3×CA; 1×67M; 10×EDO;
Assess
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated th…
5i3m
monomer107-263
1×67F; 2×ZN; 3×CA; 1×DMS; 1×PGO;
Assess
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated tr…
5i2z
monomer107-263
1×V24; 2×ZN; 3×CA; 1×PGO;
Assess
Human catalytic MMP-12 in complex with 5-(1,2-dithiolan-3-yl)-N-(3-hydroxypropyl)pentanamide
5n5k
monomer108-263
2×ZN; 3×CA; 1×HAE; 1×8NW;
Assess
Crystal structure of the catalytic domain of MMP-12 in complex with a selective sugar-conjugated tr…
5i4o
monomer108-263
1×V28; 2×ZN; 3×CA;
Assess
Crystal structure of the catalytic domain of Human MMP12 in complex with selective phosphinic inhib…
4gr8
monomer111-262
2×ZN; 3×CA; 1×R4C; 1×IMD;
Assess
Crystal structure of MMP12 in complex with hydroxamate inhibitor LP168.
6enm
monomer112-263
1×LPW; 2×ZN; 3×CA;
Assess
High-Resolution Solid-State NMR Structure of a 17.6 kDa Protein
2krj
monomer112-263
1×CO;
Assess
Paramagnetic shifts in solid-state NMR of Proteins to elicit structural information
2k9c
monomer112-263
1×CO;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3ba0.1.Amonomer0.78106-470
2×ZN; 4×CA; 1×HAE;99.73
Assess
1su3.2.Amonomer0.7230-469
3×CA; 1×ZN;49.89
Assess